SSIC RSI Chart
Last 7 days
0.4%
Last 30 days
9.0%
Last 90 days
43%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 3.6M | 5.2M | 6.3M | 6.6M |
2022 | 10.1K | 899.5K | 1.8M | 2.7M |
2021 | 0 | 0 | 0 | 0 |
Which funds bought or sold SSIC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Penserra Capital Management LLC | unchanged | - | 97,000 | 796,000 | 0.01% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | 2.00 | 17.00 | -% |
May 14, 2024 | JACOBS ASSET MANAGEMENT, LLC | reduced | -12.89 | -21,726 | 1,531,830 | 1.17% |
May 13, 2024 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | new | - | 119,606 | 119,606 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | unchanged | - | 5,503 | 45,205 | -% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Unveiling Silver Spike Investment Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Silver Spike Investment Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 372.2B | 85.6B | 9.67 | 4.35 | ||||
MRK | 332.3B | 61.4B | 144.1 | 5.41 | ||||
AMGN | 167.7B | 29.5B | 44.55 | 5.68 | ||||
PFE | 162.3B | 57.8B | 129.52 | 2.81 | ||||
GILD | 84.4B | 27.4B | 174.21 | 3.07 | ||||
TEVA | 18.4B | 16.0B | -37.29 | 1.15 | ||||
MID-CAP | ||||||||
ALKS | 4.1B | 1.7B | 9.41 | 2.37 | ||||
PRGO | 4.1B | 4.6B | -528.11 | 0.89 | ||||
BHC | 2.5B | 9.0B | -5.45 | 0.28 | ||||
AMPH | 2.1B | 676.2M | 13.75 | 3.14 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.35 | 2.06 | ||||
TXMD | 25.8M | 1.3M | -3.49 | 19.84 | ||||
ACRX | 18.4M | 89.6M | -1.29 | 0.19 | ||||
AGRX | 2.5M | 21.5M | -0.32 | 0.12 | ||||
ACOR | 633.5K | 115.7M | 0 | 0.01 |
Silver Spike Investment Corp News
Income Statement (Quarterly) | |||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -100.0% | - | 1,741,723 | 1,616,986 | 1,899,412 | 1,370,723 | 1,425,327 | 550,415 | 221,245 | - | - |
S&GA Expenses | - | - | - | - | - | - | - | - | - | 34,168 | - |
Net Income | 44.1% | -1,033,851 | -1,850,234 | -2,641,361 | 1,211,404 | 2,357,080 | 1,151,979 | 559,923 | 211,737 | 85,059,639 | - |
Net Income Margin | -367.3% | -0.65 | -0.14 | 0.33 | 1.01 | 1.20 | 32.48 | 47.35 | 94.18 | 8,410 | - |
Free Cashflow | -70.5% | 2,103,079 | 7,138,994 | 840,198 | 351,633 | -2,581,293 | 437,400 | 437,400 | -24,147,613 | -509,110 | - |
Balance Sheet | ||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q1 |
Assets | 2.0% | 90.00 | 89.00 | 89.00 | 91.00 | 90.00 | 87.00 | 85.00 |
Cash Equivalents | 1.7% | 33.00 | 33.00 | 30.00 | 33.00 | 33.00 | 35.00 | 85.00 |
Liabilities | 92.9% | 6.00 | 3.00 | 2.00 | 1.00 | 1.00 | 0.00 | 0.00 |
Shareholder's Equity | -1.2% | 85.00 | 86.00 | 87.00 | 90.00 | 89.00 | 86.00 | 85.00 |
Retained Earnings | -227.8% | -0.57 | 0.00 | 2.00 | 5.00 | 4.00 | 1.00 | -0.43 |
Additional Paid-In Capital | 0.0% | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 |
Shares Outstanding | 0% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Float | - | - | - | - | 14.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q1 |
Cashflow From Operations | -70.5% | 2,103 | 7,139 | 840 | 352 | -2,581 | - | 437 | -24,147 | -509 | - | - |
Cashflow From Financing | 64.3% | -1,554 | -4,348 | -3,914 | - | - | - | - | - | 85,270 | - | - |
Dividend Payments | -100.0% | - | 4,348 | - | - | - | - | - | - | - | - | - |
Statements of Operations - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Non-control/non-affiliate investment income | ||
Fee income | $ 33,750 | $ 0 |
EXPENSES | ||
Transaction expenses related to the Loan Portfolio Acquisition | 2,106,050 | 0 |
Management fee | 246,131 | 238,419 |
Capital gains incentive fees | 119,924 | 142,602 |
Audit expense | 106,625 | 97,883 |
Administrator fees | 98,456 | 77,844 |
Insurance expense | 66,279 | 69,082 |
Legal expenses | 58,051 | 98,760 |
Other expenses | 19,191 | 19,504 |
Custodian fees | 11,850 | 12,000 |
Director expenses | 5,526 | 35,944 |
Valuation fees | 1,973 | 73,065 |
Income-based incentive fees | 0 | 203,821 |
Professional fees | 0 | 18,192 |
Total expenses | 2,840,056 | 1,087,116 |
NET INVESTMENT INCOME (LOSS) | (79,809) | 1,370,723 |
NET REALIZED GAIN (LOSS) FROM INVESTMENTS | ||
Net realized gain (loss) from investments | 0 | 0 |
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) FROM INVESTMENTS | ||
Net change in unrealized appreciation (depreciation) from investments | 599,620 | 986,357 |
Net realized and unrealized gains (losses) | 599,620 | 986,357 |
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS | $ 519,811 | $ 2,357,080 |
NET INVESTMENT INCOME (LOSS) PER SHARE - BASIC (in dollars per share) | $ (0.01) | $ 0.22 |
NET INVESTMENT INCOME (LOSS) PER SHARE - DILUTED (in dollars per share) | (0.01) | 0.22 |
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC (in dollars per share) | 0.08 | 0.38 |
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED (in dollars per share) | $ 0.08 | $ 0.38 |
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC (in shares) | 6,214,941 | 6,214,672 |
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED (in shares) | 6,214,941 | 6,214,672 |
Investment, Unaffiliated Issuer [Member] | ||
Non-control/non-affiliate investment income | ||
Interest income | $ 2,726,497 | $ 2,457,839 |
Fee income | 33,750 | 0 |
Total investment income | 2,760,247 | 2,457,839 |
NET REALIZED GAIN (LOSS) FROM INVESTMENTS | ||
Net realized gain (loss) from investments | 0 | 0 |
NET CHANGE IN UNREALIZED APPRECIATION (DEPRECIATION) FROM INVESTMENTS | ||
Net change in unrealized appreciation (depreciation) from investments | $ 599,620 | $ 986,357 |
 | Mr. Scott Gordon |
---|---|
 | Pharmaceuticals |